Takeda May Sell Shire Pipeline Drug to Clear EU Antitrust Review

(Bloomberg) -- Takeda Pharmaceutical Co. is in talks with European antitrust regulators about selling an experimental inflammatory bowel disease drug to help close its $62 billion takeover of Shire...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.